Introduction {#Sec1}
============

Since the Cabinet's decision concerning the Basic Policies for Economic and Fiscal Management and Structural Reform 2005 \[[@CR1]\], the Japanese government has implemented measures to moderate healthcare costs specifically to suppress increases in national medical care expenditure. Unfortunately, these measures did not take into account the stimulatory effects of medical care on the economy. For example, to provide medical care, health sectors such as medical institutions participate in interindustry transactions as they purchase goods and services such as drugs, medical supplies, and equipment. The health sector also stimulates the economy through the provision of employment and indirectly supports the societal role of employees as consumers.

The importance of identifying the economic impact of the social security which influences the expansion of domestic demand has been emphasized by the Annual Reports on Health and Welfare in Japan \[[@CR2]\]. National medical care expenditure supports economic activities of medical institutions and contributes to stimulation of other economic sectors involved in interindustry transactions with medical institutions. Such transactions with medical institutions comprise the so-called economic impact of medical care. The Japanese government recognize the need to clarify this impact. Thus, it is essential to quantitatively evaluate the economic impact of medical care.

Economic impact is commonly assessed by an Input--Output (I--O) analysis which uses an I--O table. Developed by Wassily Leontief, the I--O analysis is a method to systematically quantify the mutual interrelationships among the various sectors of a complex economic system \[[@CR3]\]. The I--O table, a statistical data table for the I--O analysis, describes the flow of goods and services between all the individual sectors of a national economy over a year \[[@CR4]\]. The I--O table for Japan is developed every 5 years by the Ministry of Internal Affairs and Communications (MIC) and 9 other ministries as a joint enterprise. Each prefecture and some cities in Japan also develop I--O tables that reflect their regional economy. The I--O table for Japan is elaborately developed and adopts a wide range of statistical reports. It is well known for its high data accuracy, reliability and accessibility. I--O analysis with this table is generally applied by government and public sectors as they evaluate the impact of a public investment, airport development or tourism industry. The economic impact estimated by the equilibrium output model using an I--O analysis evaluates the gaining economic effect on the economic front at the same time; this is separate from a direct evaluation of the policy objectives \[[@CR5]\].

The necessity to identify the economic importance of the health sector has been widely discussed, and the I--O analysis is an established method to assess economic impact. Data from an I--O table have assessed economic impact of the health sector in such areas as cities, part of regions, counties, prefectures and a nation \[[@CR6]--[@CR9]\]. Other studies examined impact with an I--O analysis using data from a Statement of Profits and Losses (P/L), which allows for the estimation of impact on specific target regions or medical institutions \[[@CR10]--[@CR14]\]. Although each of these studies uses a different analysis model, estimated impacts range from 1.5 to 2.5 times of the final demand. However, I--O analysis and P/L data have not been used to evaluate the economic impact of the health sector, particularly the medical care of all medical institutions in Japan.

To address these concerns, the following are the objectives of this study: to use I--O analysis and P/L data to quantitatively estimate the economic impact of medical care dispensed by all medical institutions, and to examine the estimation range of the economic impact with a probabilistic sensitivity analysis.

Materials and methods {#Sec2}
=====================

Data used in the analysis {#Sec3}
-------------------------

We used the following data and model as basic data to develop a spreadsheet for the I--O analysis model.

Medical revenue and medical cost {#Sec4}
--------------------------------

We estimated medical revenue and medical cost from the total general medical care expenditure and hospitalization meal expenses. National-level cost for the total general medical care expenditure comprised the expenditures from public expense, social insurance and personal expenses paid to medical institutions. This was equivalent to the total medical revenue for all medical institutions. Institutional-level medical cost estimated in the following section was covered by medical revenue and represents the cost of providing medical services. General medical care expenditure consisted of hospitalization expenses and hospitalization outpatient expenses of hospitals and medical clinics. These data were provided by the Estimates of National Medical Care Expenditure 2005 of the Ministry of Health, Labour and Welfare \[[@CR15]\].

We also estimated medical cost from the total general medical care expenditure and hospitalization meal expenses. Since detailed expense data were not available from Estimates of National Medical Care Expenditure 2005, further calculations were required to estimate medical cost for expense items for all medical institutions. We estimated the percentage of medical cost for each expense item per facility using the P/L data per facility per month for hospitals, special functioning hospitals and medical clinics (Fig. [1](#Fig1){ref-type="fig"}). We derived the P/L data from the Medical Economics Survey, June 2005, of the Central Social Insurance Medical Council \[[@CR16]\].Fig. 1Estimation of medical cost for each expense item of all medical institutions

First, we estimated the percentage of medical cost for each expense item for all hospitals and special functioning hospitals. In this process, we multiplied the number of facilities with valid replies by the P/L data per facility per month for hospitals and special functioning hospitals. Next, we summed the medical cost for each expense item of hospitals and special functioning hospitals. Then, we divided this total medical cost by the total number of hospitals and special functioning hospitals. We estimated the percentage for each expense item for all the hospitals ({1} in Fig. [1](#Fig1){ref-type="fig"}). We also estimated this percentage of medical cost for each expense item for medical clinics ({2} in Fig. [1](#Fig1){ref-type="fig"}).

Compared with medical cost, medical revenue was higher for all hospitals and lower for medical clinics, according to P/L data of the Medical Economics Survey. Therefore, we estimated medical cost by multiplying medical care expenditure, which consisted of general medical care expenditure and hospitalization meal expenses, by the ratio of medical revenue to medical cost ({3} in Fig. [1](#Fig1){ref-type="fig"}).

To estimate medical cost for each expense item for all the hospitals, we allocated the total amount of general medical care expenditure and hospitalization meal expenses according to the percentage for each expense item. General medical care expenditure refers to the total amount of hospitalization expenses and hospitalization outpatient expenses of hospitals ({4} in Fig. [1](#Fig1){ref-type="fig"}). As for medical clinics, we allocated general medical care expenditure, which was a total of hospitalization expenses and hospitalization outpatient expenses of medical clinics, according to the percentage for each expense item ({5} in Fig. [1](#Fig1){ref-type="fig"}).

The sum of medical cost for each expense item for all hospitals and medical clinics estimated medical cost for each expense item for all medical institutions as basic data ({6} in Fig. [1](#Fig1){ref-type="fig"}). Of national medical care expenditure, we excluded dentistry expenses, pharmacy medical expenses and home nursing expenses for the estimation of medical revenue and medical cost ({7} in Fig. [1](#Fig1){ref-type="fig"}). Because P/L data based on the Medical Economics Survey, June 2005, of the Central Social Insurance Medical Council \[[@CR16]\] included both nursing insurance and healthcare insurance data, excluding nursing insurance-specific data is difficult. We focused on general medical care expenditures of hospitals and medical clinics including hospitalization meal expenses covered by healthcare insurance, which amounted to 78 % of national medical care expenditure.

I--O table {#Sec5}
----------

I--O analysis incorporated data from the 2000 I--O table (transactions valued at producers' prices) 32 sectors of the MIC \[[@CR17]\]. Trade margin rates, domestic transportation charge rates and employee income rates were calculated from this I--O table as stated in following section. The data we used, therefore, represent total economic activity in 2000. We applied 2000 I--O table 32 sectors instead of 104 sectors because medical cost used as intermediate demand was classified into 21 broad expense items and this did not correspond to 104 detailed sectors.

Trade margin rates and domestic transportation charge rates {#Sec6}
-----------------------------------------------------------

Trade margin rates and domestic transportation charge rates are outlined in a study of Yasuda \[[@CR18]\] that calculated rates by dividing the margin by the purchasers' price from the I--O table. A trade margin table and a domestic transportation charge table attached to the I--O table in some studies calculated margin rates for input to the I--O analysis model. These margin rates, however, represented all transactions in industrial sectors and were not able to cover the final demand specifically \[[@CR18]\].

Employee income rates {#Sec7}
---------------------

Employee income rates equaled employee income divided by domestic production from the I--O table.

Consumption propensity {#Sec8}
----------------------

Consumption propensity was consumption expenditure divided by income of workers' households from the 2006 Annual Report on the Family Income and Expenditure Survey, Income and Expenditure of the MIC \[[@CR19]\]. This was one of the key data items used to estimate economic impact through consumption. As such, we evaluated the distribution of consumption propensity using a probabilistic sensitivity analysis.

Equilibrium output model {#Sec9}
------------------------

This study used a competitive import equilibrium output model to consider exported and imported economic impact. The equilibrium output model estimated domestic induced production value (*X*) (column vector) \[[@CR20]\]:$$\documentclass[12pt]{minimal}
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Data analysis {#Sec10}
-------------

### I--O analysis {#Sec11}

Given the availability of the I--O table and applicability of the impact analysis, we used the I--O analysis for the present study. Aside from the I--O analysis, one other model that can estimate the economic impact is the allied general equilibrium analysis. This model takes advantage of a distinctive feature of the I--O table which indicates business relations of goods among industries \[[@CR21]\]. It also corresponds to supply constraints by introducing competitive capital and labor markets, and specifically indicates an act of a household, company or government.

The I--O analysis model, or the equilibrium output model, only estimates domestic production inducement value. We allocated medical care expenditure, or medical revenue, as a direct effect in this model because economic impact was induced by production value which corresponded to an increase in medical revenue. Studies tend to use intermediate demand or medical cost, rather than final demand to estimate economic impact \[[@CR10]--[@CR13]\]. Induced production values estimated in this manner become a deducted value, as the estimation is not based on final demand but on smaller intermediate demand \[[@CR22]\]. We therefore allocated medical care expenditure, or medical revenue, as a direct effect in the estimation of the economic impact in this study. The I--O analysis in Model 2, which allocated medical cost for direct effect, directly estimated economic impact to compare these results with previous studies that used intermediate demand.

According to prerequisites of the I--O analysis, input is proportional to output and lower costs derived from mass production, or economies of scale, are not accounted for in the analysis and vice versa \[[@CR23]\]. The other prerequisite is that estimation of economic impact from investment value is not possible. It is difficult to identify where and when investments occur, making it unsuitable to add investment value in the I--O analysis model \[[@CR24]\]. Hence, we excluded expense items of depreciations from P/L data from the analysis.

The I--O analysis model consisted of two routes: a route that estimated economic impact through purchasing raw materials (raw materials\' purchase route), and a route that estimated economic impact through consumption, (consumption route). The I--O analysis model of each route followed the order using the basic data (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Flow chart of the I--O analysis model

First, we analyzed the raw materials\' purchase route. We allocated medical revenue as a direct effect to account for the economic impact of the purchase of raw materials ({1} in Fig. [2](#Fig2){ref-type="fig"}). We allocated medical cost to the I--O table ({2} in Fig. [2](#Fig2){ref-type="fig"}). Multiplying purchasers' prices by trade margin rates and domestic transportation charge rates converted purchasers' prices of medical cost, which excluded personnel expenses, to producers' prices ({3} in Fig. [2](#Fig2){ref-type="fig"}).

Medical cost was added to the equilibrium output model as domestic final demand to estimate economic impact of the raw materials\' purchase route, or indirect effect ({4} in Fig. [2](#Fig2){ref-type="fig"}). To calculate a primary impact, we added the pre-effect (direct effect) to the economic impact of the raw materials\' purchase route (indirect effect) as shown in {5} in Fig. [2](#Fig2){ref-type="fig"}.

Next, we analyzed the consumption route. Employee income equaled the primary impact multiplied by employee income rates ({6} in Fig. [2](#Fig2){ref-type="fig"}). To calculate total employee income, we added personnel expenses in medical cost to employee income ({7} in Fig. [2](#Fig2){ref-type="fig"}). Multiplying consumption propensity by total employee income equaled household consumption ({8} in Fig. [2](#Fig2){ref-type="fig"}).

Household consumption was added to the equilibrium output model to estimate economic impact of the consumption route, or a secondary impact ({9} in Fig. [2](#Fig2){ref-type="fig"}). Economic impact was the sum of the primary and the secondary impact. Economic impact multipliers, or induced production coefficients, equaled this economic impact divided by direct effect.

### Probabilistic sensitivity analysis {#Sec12}

We used the Monte Carlo simulation for probabilistic sensitivity analysis to identify uncertainty of economic impact and economic impact multipliers, estimated using the I--O analysis, with 95 % confidence interval (CI). Monte Carlo simulations use sampling experiments to estimate the distribution of output variables that depend on several probabilistic input variables \[[@CR25]\]. We selected consumption propensity and percentage of medical cost for each expense item from P/L data as input variables and adjusted the theoretical probabilistic distribution for these variables in order to run the simulations.

Twenty years of observed data from 1987 to 2006 collected from the Annual Report on the Family Income and Expenditure Survey, Income and Expenditure, of the MIC \[[@CR19], [@CR26]\] were used to calculate consumption propensity. To verify the stability of this data, we analyzed the distribution with a histogram and descriptive statistics. We fit these data to a normal probability distribution with a mean of 62 %, a standard deviation of 0.01, and a lower and upper limit range of 57 and 67 %, respectively.

For the percentage of medical cost for each expense item, we selected 19 and 13 expense items from all hospitals and medical clinics, respectively. Triangular distribution defined each of these expense items with observed data from five previous surveys conducted in September 1997, June 1999, June 2001, June 2003 and June 2005 from the Medical Economics Survey \[[@CR16]\]. Uniform distribution defined expense items with fewer than two observed data, and triangular distribution defined the remaining expense items. The average of surveys from June 2005 and June 2003 determined the maximum likelihood value of triangular distribution. We obtained minimum and maximum values by fitting observed data in a probabilistic distribution using analysis software.

We defined indirect effect, primary impact, secondary impact, economic impact and the multipliers of each for the output variables.

We conducted repeated random sampling 1000 times according to the probability distribution of the input variables. Sampling data incorporated in the spread sheet I--O analysis model produced a normal distribution of output variables and identified the 95 % CI. Crystal Ball^®^ 2000 Professional Edition (Decisioneering, Inc.) \[[@CR27]\] was the analysis software for the Monte Carlo simulation.

Results {#Sec13}
=======

Allocation of medical revenue and medical cost of all medical institutions indicated that total medical revenue was ¥25,948.4 billion (\$238.1 billion: US\$1 = JPN¥109) and medical cost was ¥23,329.7 billion (\$214.1 billion) (Table [1](#Tab1){ref-type="table"}). Next to employee compensation (49 %), the largest allocation from medical cost was for chemical products (18 %).Table 1Medical revenue and medical cost for each sector of the I--O tableExpense itemsSectors of the I--O tableValue in billionsMedical revenue¥25,948.4\
(\$238.1) Inpatient revenue, outpatient revenue, other revenueMedical service, health and social security and nursing care¥25,948.4\
(\$238.1)Medical cost¥24,825.6\
(\$227.8) Personal expensesCompensation of employees¥12,218.4\
(\$112.1) Material costs  MedicineChemical products¥4,387.2\
(\$40.3)  Food materialFoods¥196.4\
(\$1.8)  Medical materials and medical consumables, dental materials, othersMiscellaneous manufacturing products¥2,025.9\
(\$18.6) Expenses  Utility costsElectricity, gas and heat supply¥353.4\
(\$3.2)  Land rents, building rentsReal estate¥467.6\
(\$4.3)  Equipment rentals (medical equipment, other equipment), other utility costsBusiness services¥2,156.5\
(\$19.8) Consignment costs  Laboratory tests, dental technologies, medical clerks, othersBusiness services¥1,063.2\
(\$9.8)  Meal service for patientsFoods¥210.3\
(\$1.9)  Linen cleanings/rentals, patient gown cleanings/rentalsPersonal services¥70.0\
(\$0.6)  Medical waste disposalsWater supply and waste management services¥48.7\
(\$0.5) Depreciations  Buildings, medical equipments, othersDepreciation of fixed capital¥1,495.9\
(\$13.7) OthersBusiness services¥132.0\
(\$1.2)

The total economic impact of all medical institutions, primary and secondary impact, was ¥72,107.4 billion (\$661.5 billion) with a 95 %CI ranging from ¥71,018.2 billion (\$651.5 billion) to ¥75,300.0 billion (\$690.8 billion) (Table [2](#Tab2){ref-type="table"}). The impact of the raw materials\' purchase route, or indirect effect, induced from the medical cost, was ¥18,474.3 billion (\$169.5 billion). The impact of the consumption route, or secondary impact, stimulated from the primary impact was ¥27,684.7 billion (\$254.0 billion). The economic impact multiplier (induced production coefficient), which divided the economic impact by the direct effect, was 2.78 (95 % CI 2.74--2.90).Table 2Economic impact and economic impact multipliers of all medical institutionsImpact categoriesImpact value in billions95 % CIEconomic impact multipliers95 % CIEconomic impact: primary impact plus secondary impact¥72,107.4\
(\$661.5)¥71,018.2\
(\$651.5)¥75,300.0\
(\$690.8)2.782.742.90Primary impact¥44,422.7\
(\$407.5)¥43,214.5\
(\$396.5)¥45,799.9\
(\$420.2)1.711.671.77 (Direct effect: medical care expenditure, or medical revenue)¥25,948.4\
(\$238.1)----1.00---- (Indirect effect: economic impact of the raw materials\' purchase route)¥18,474.3\
(\$169.5)¥17,266.1\
(\$158.4)¥19,851.5\
(\$182.1)0.710.670.77Secondary impact: economic impact of the consumption route¥27,684.7\
(\$254.0)¥27,237.4\
(\$249.9)¥30,096.2\
(\$276.1)1.071.051.16

The percentage of public expenditure within national medical care expenditure is 36 %, which is equivalent to ¥12,061.0 billion (\$110.7 billion) \[[@CR15]\]. By multiplying this by the induced production value, or the economic impact, the impact of the public expenditure can be estimated, amounting to ¥25,958.7 billion (\$238.1 billion). The job creation effect was estimated by multiplying the economic impact by employment rate equal to 4946 thousand employees (95 % CI 4876 thousand--5119 thousand). Employment rates were calculated by dividing the number of employees from the I--O table (employment table) \[[@CR28]\] by the domestic production from the I--O table \[[@CR17]\].

Economic impact estimated as Model 2 was ¥34,638.9 billion (\$317.8 billion) with a 95 % CI ranging from ¥33,475.3 billion (\$307.1 billion) to ¥37,227.6 billion (\$341.5 billion) with an economic impact multiplier of 1.40 (95 % CI 1.38--1.46).

Discussion {#Sec14}
==========

This study revealed that economic impact of all medical care by medical institutions in Japan totaled ¥72,107.4 billion (\$661.5 billion), equal to 2.78 times the ¥25,948.4 billion (\$238.1 billion) outlaid for medical care expenditure. Estimation of the economic impact was performed as a way to evaluate quantitatively the economic effects, including various aspects of medical care, obtained from the economic front through medical policy measures. No previous studies have identified the economic impact of medical care by all medical institutions throughout Japan using P/L data. We quantitatively identified the volume of influences that medical care expenditure has on the Japanese economy using P/L data. To date, no probabilistic sensitivity analysis has been conducted on the economic impact. We used the Monte Carlo simulation for the probabilistic sensitivity analysis and indicated the uncertainty derived from the consumption propensity and P/L data in the I--O analysis model with an estimation range of the economic impact.

Contributions to the direct effect {#Sec15}
----------------------------------

Estimates of economic impact in all medical institutions were higher in this study compared to the group of Previous Studies A outlined in Fig. [3](#Fig3){ref-type="fig"}. Among those studies, Doi and Nakano \[[@CR13]\] estimated economic impact of a public hospital using P/L data in the same manner as our study to be 1.64 times medical care expenditure. The disparities between this study and the Previous Studies A resulted from differences in accounting for contributions to the direct effect. Our study applied medical care expenditure, or medical revenue, to the direct impact, whereas Doi and Nakano \[[@CR13]\] applied medical cost. In consideration of their analysis model, we examined economic impact multipliers, or induced production coefficients, from Model 2 and applied medical cost to the direct effect. As a result of applying this method, the Model 2 multiplier was 1.40, which was similar to results from their study. The economic impact of their study deducted the amount of medical revenue, resulting in a relatively small economic impact.Fig. 3Comparison of economic impact multipliers from previous studies. ^a^Previous studies which estimated economic impact multipliers using P/L data and the I--O table in the same manner as our study. In contrast to the analysis model from this study, these studies applied medical cost instead of medical care expenditure, or medical revenue. ^b^Previous studies that analyzed data from the I--O table to estimate economic impact multipliers. ^c^Economic impact multipliers of this study as well as Model 2 indicate point estimates and 95 % CI. ^d^Doi and Nakano \[[@CR12]\]. ^e^Doeksen and Schott \[[@CR10]\]. ^f^Tsukahara \[[@CR5]\]

A direct comparison of results from them with results from our study is difficult because they estimated the economic impact based on one prefecture. In addition, other than medical cost, they included nonmedical cost not included in this study, such as store cost and visitor travel cost. Most importantly, economic impact of all medical institutions in this study was estimated with a theoretically valid methodology compared to the results of Doi and Nakano \[[@CR13]\], which estimated economic impact excluding medical care expenditure, or medical revenue, which must be applied to direct effect.

Economic impact multiplier {#Sec16}
--------------------------

Tsukahara \[[@CR6]\] of Previous Studies B analyzed data from the I--O table to estimate economic impact multipliers instead of using P/L data. This study identified the medical service sector economic impact multiplier to be 2.33 and transportation equipment sector, including automobile manufacturers, to be 3.15, if consumption propensity equaled 60 %. In comparison with these medical service sector results, medical care of all medical institutions from our study evidently indicated an elevated economic impact multiplier of 2.78. Given these differences in analysis models, further studies are needed to explore the effects of analytical differences on results.

Uncertainty of consumption propensity {#Sec17}
-------------------------------------

Tsukahara \[[@CR6]\] noted that rather than a reliance on a flat consumption propensity, the adoption of a marginal propensity to consume, a percentage of consumption that alters when income increases, was preferable. In response to this uncertainty, we incorporated a normal distribution into the probabilistic sensitivity analysis with a consumption propensity ranging from 57 to 67 %.

Study limitations {#Sec18}
-----------------

This study estimated economic impact of the medical care of all medical institutions from medical care expenditure, a total of general medical care expenditure and hospitalization meal expenses out of national medical care expenditure. However, we excluded dentistry expenses, pharmacy medical expenses and home nursing expenses in this study because of unavailability of detailed data. These expenses accounted for 22 % of national medical care expenditure; therefore, further analysis incorporating these excluded data is needed to identify the true economic impact of all medical care.

Conclusion {#Sec19}
==========

In conclusion, medical care expenditures represent a resource for medical institutions that allow them to continuously provide medical services which contribute to the well-being of the whole nation. As such, any shortage in this expenditure can severely affect the quantity and quality of medical services for those who need medical care. It also supports the economic activities of medical institutions and helps stimulate other economic sectors involved in interindustry transactions with medical institutions. These transactions, in turn, stimulate the economy through the provision of employment and indirectly support the societal role of employees as consumers.

This study identified the economic impact of medical care other than the job creation effect in Japan to be 2--3 times the input (in units) allocated from medical care expenditure. Medical care had as strong a production inducement as other sectors recognized as industries with high economic effects. The Japanese government had taken measures to suppress national medical care expenditure; however, when evaluating national medical care expenditure policies, it is necessary to evaluate the contribution to medical care more explicitly, particularly regarding the economic stimulation through the maintenance and production of employment in various industries related to medical care.

Besides the economic impact, evaluation of the medical institutions should consider the impact of medical care on society as well. Further studies are needed to quantify the impact and importance of medical institutions in terms of benefit toward people who live in the society.
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